Global Multiplex Assays Market, By Product, By Type, By Technology, By Application (Research & Development, Clinical Diagnosis, By End User, By Region, forecast & opportunities, 2026

Description

Global multiplex assays market is expected to undergo substantial rate of growth during the forecast period owing to technological advancements in healthcare sector, especially rapid development in nano technology. Increasing prevalence of chronic diseases including cancer, where multiplex assays are significantly used, is also a major driving factor for the growth of this market. Additionally, various benefits of multiplex assays over singleplex and other traditional diagnostics is also anticipated to fuel the growth of multiplex market in the years to come.

Multiplex assay is a type of assay which measures multiple analytes in a single cycle. They are widely used in functional genomics to determine the effects of experimental treatments. A multiplex assay detects proteins and other biomolecules in a biological sample.

Global multiplex assays market can be segmented based on product, type, technology, application, end user and region. Based on technology, the market is segmented into flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR and others. The flow cytometry segment is expected to undergo significant growth during the forecast period as it works on the basis of bead population, which is helpful in computing specific antibody levels in biological fluids.

Region wise, North America is expected to dominate the global multiplex assays market by 2026 owing to regions' advanced healthcare system and availability of trained professionals. Various governments in the region are also supporting the development of advanced technologies for diagnostics, which is giving a major boost to multiplex assay companies.

Major companies operating in global multiplex assays market include Thermo Fisher Scientific Inc, Luminex Corporation, Illumina Inc, Qiagen N.V., Bio Rad Laboratories Inc, Abcam Plc, Agilent Technologies, Merck Sharp & Dohme Corp, Randox Laboratories Ltd, Meso Scale Diagnostics LLC, Seegene Inc., Becton, Dickinson and Company, Quansys Biosciences, Olink, Bio-Techne, Johnson & Johnson Services, Inc. and Hoffmann-La Roche Ltd, among others. Prominent market players are extensively undergoing research and development activities in order to introduce superior quality assays in the market.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022-2026

Objective of the Study:

To analyze and forecast the market size of global multiplex assays market.
To forecast global multiplex assays market based on product, type, technology, application, end user, company and regional distribution.
To identify drivers and challenges for global multiplex assays market.
To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global multiplex assays market.
To identify and analyze the profile of leading players operating in the global multiplex assays market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of multiplex assays manufacturing companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research.

TechSci Research calculated global multiplex assays market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analysing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.

Key Target Audience:

Multiplex assays manufacturers, vendors and other stakeholders
Government bodies such as regulating authorities and policy makers
Organizations, industry associations, forums and alliances related to multiplex assays
Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as multiplex assays manufacturing companies, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global multiplex assays market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Multiplex Assays Market, By Product:

Reagents & Consumables

Accessories & Instruments

Software & Services

Global Multiplex Assays Market, By Type:

Nucleic Acid

Protein

Cell-based

Global Multiplex Assays Market, By Technology:

Flow Cytometry

Fluorescence Detection

Luminescence

Multiplex Real-Time PCR

Others

Global Multiplex Assays Market, By Application:

Research & Development

Drug Development
Biomarker Discovery & Validation

Clinical Diagnosis

Infectious Disease
Cancer
Cardiovascular Disease
Autoimmune Disease
Nervous System Disorders
Others
Global Multiplex Assays Market, By End User:

Pharmaceutical & Biotechnology Companies

Hospitals & Research Institutes

Reference Laboratories

Others

Global Multiplex Assays Market, By Region:

Asia-Pacific

China
Japan
India
South Korea
Australia

Europe

France
Germany
United Kingdom
Italy
Spain

North America

United States
Mexico
Canada

South America

Brazil
Argentina
Colombia

Middle East & Africa

South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global multiplex assays market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Profit Margin Analysis

Profit margin analysis in case of direct and indirect sales channel.

Product Code: 5055

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Multiplex Assays Market

4. Executive Summary

5. Voice of Customer

6. Global Multiplex Assays Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
- 6.2.2. By Type (Nucleic Acid, Protein, Cell-based)
- 6.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
- 6.2.4. By Application (Research & Development v/s Clinical Diagnostics)
  - 6.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
  - 6.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
- 6.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
- 6.2.6. By Company (2021)
- 6.2.7. By Region
6.3. Product Market Map

7. Asia-Pacific Multiplex Assays Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
- 7.2.2. By Type (Nucleic Acid, Protein, Cell-based)
- 7.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
- 7.2.4. By Application (Research & Development v/s Clinical Diagnostics)
  - 7.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
  - 7.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
- 7.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
- 7.2.6. By Country
7.3. Asia-Pacific: Country Analysis
- 7.3.1. China Multiplex Assays Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By Type
    - 7.3.1.2.3. By Technology
    - 7.3.1.2.4. By Application
    - 7.3.1.2.5. By End User
- 7.3.2. India Multiplex Assays Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By Type
    - 7.3.2.2.3. By Technology
    - 7.3.2.2.4. By Application
    - 7.3.2.2.5. By End User
- 7.3.3. Japan Multiplex Assays Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By Type
    - 7.3.3.2.3. By Technology
    - 7.3.3.2.4. By Application
    - 7.3.3.2.5. By End User
- 7.3.4. South Korea Multiplex Assays Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By Type
    - 7.3.4.2.3. By Technology
    - 7.3.4.2.4. By Application
    - 7.3.4.2.5. By End User
- 7.3.5. Australia Multiplex Assays Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By Type
    - 7.3.5.2.3. By Technology
    - 7.3.5.2.4. By Application
    - 7.3.5.2.5. By End User

8. Europe Multiplex Assays Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
- 8.2.2. By Type (Nucleic Acid, Protein, Cell-based)
- 8.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
- 8.2.4. By Application (Research & Development v/s Clinical Diagnostics)
  - 8.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
  - 8.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
- 8.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
- 8.2.6. By Country
8.3. Europe: Country Analysis
- 8.3.1. France Multiplex Assays Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By Type
    - 8.3.1.2.3. By Technology
    - 8.3.1.2.4. By Application
    - 8.3.1.2.5. By End User
- 8.3.2. Germany Multiplex Assays Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By Type
    - 8.3.2.2.3. By Technology
    - 8.3.2.2.4. By Application
    - 8.3.2.2.5. By End User
- 8.3.3. United Kingdom Multiplex Assays Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By Type
    - 8.3.3.2.3. By Technology
    - 8.3.3.2.4. By Application
    - 8.3.3.2.5. By End User
- 8.3.4. Italy Multiplex Assays Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By Type
    - 8.3.4.2.3. By Technology
    - 8.3.4.2.4. By Application
    - 8.3.4.2.5. By End User
- 8.3.5. Spain Multiplex Assays Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By Type
    - 8.3.5.2.3. By Technology
    - 8.3.5.2.4. By Application
    - 8.3.5.2.5. By End User

9. North America Multiplex Assays Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
- 9.2.2. By Type (Nucleic Acid, Protein, Cell-based)
- 9.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
- 9.2.4. By Application (Research & Development v/s Clinical Diagnostics)
  - 9.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
  - 9.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
- 9.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
- 9.2.6. By Country
9.3. North America: Country Analysis
- 9.3.1. United States Multiplex Assays Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By Type
    - 9.3.1.2.3. By Technology
    - 9.3.1.2.4. By Application
    - 9.3.1.2.5. By End User
- 9.3.2. Mexico Multiplex Assays Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By Type
    - 9.3.2.2.3. By Technology
    - 9.3.2.2.4. By Application
    - 9.3.2.2.5. By End User
- 9.3.3. Canada Multiplex Assays Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By Type
    - 9.3.3.2.3. By Technology
    - 9.3.3.2.4. By Application
    - 9.3.3.2.5. By End User

10. South America Multiplex Assays Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
- 10.2.2. By Type (Nucleic Acid, Protein, Cell-based)
- 10.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
- 10.2.4. By Application (Research & Development v/s Clinical Diagnostics)
  - 10.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
  - 10.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
- 10.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
- 10.2.6. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Multiplex Assays Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By Type
    - 10.3.1.2.3. By Technology
    - 10.3.1.2.4. By Application
    - 10.3.1.2.5. By End User
- 10.3.2. Colombia Multiplex Assays Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By Type
    - 10.3.2.2.3. By Technology
    - 10.3.2.2.4. By Application
    - 10.3.2.2.5. By End User

11. Middle East and Africa Multiplex Assays Market Outlook

11.1. Market Size & Forecast
- 11.1.1. By Value
11.2. Market Share & Forecast
- 11.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
- 11.2.2. By Type (Nucleic Acid, Protein, Cell-based)
- 11.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
- 11.2.4. By Application (Research & Development v/s Clinical Diagnostics)
  - 11.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
  - 11.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
- 11.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
- 11.2.6. By Country
11.3. MEA: Country Analysis
- 11.3.1. South Africa Multiplex Assays Market Outlook
  - 11.3.1.1. Market Size & Forecast
    - 11.3.1.1.1. By Value
  - 11.3.1.2. Market Share & Forecast
    - 11.3.1.2.1. By Product
    - 11.3.1.2.2. By Type
    - 11.3.1.2.3. By Technology
    - 11.3.1.2.4. By Application
    - 11.3.1.2.5. By End User
- 11.3.2. Saudi Arabia Multiplex Assays Market Outlook
  - 11.3.2.1. Market Size & Forecast
    - 11.3.2.1.1. By Value
  - 11.3.2.2. Market Share & Forecast
    - 11.3.2.2.1. By Product
    - 11.3.2.2.2. By Type
    - 11.3.2.2.3. By Technology
    - 11.3.2.2.4. By Application
    - 11.3.2.2.5. By End User
- 11.3.3. UAE Multiplex Assays Market Outlook
  - 11.3.3.1. Market Size & Forecast
    - 11.3.3.1.1. By Value
  - 11.3.3.2. Market Share & Forecast
    - 11.3.3.2.1. By Product
    - 11.3.3.2.2. By Type
    - 11.3.3.2.3. By Technology
    - 11.3.3.2.4. By Application
    - 11.3.3.2.5. By End User

12. Market Dynamics

12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

14.1. Competition Outlook
14.2. Company Profiles
- 14.2.1. Abbott Laboratories, Inc.
- 14.2.2. Thermo Fisher Scientific, Inc.
- 14.2.3. Danaher Corporation
- 14.2.4. F. Hoffmann-La Roche AG
- 14.2.5. Siemens Healthineers AG
- 14.2.6. Bio-Rad Laboratories, Inc.
- 14.2.7. bioMerieux SA
- 14.2.8. BUHLMANN Laboratories AG
- 14.2.9. Sekisui Medical Co., Ltd.
- 14.2.10. Randox Laboratories Ltd.